Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

July 1, 2026

Conditions
Chronic Kidney Disease(CKD)Type 1 Diabetes (T1D)
Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

The Cleveland Clinic

OTHER

NCT06694558 - Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease | Biotech Hunter | Biotech Hunter